TP-5809

N/A

Report date: 2024/04/29 17:39:36
NME

Base Information

Drug NameTP-5809
Drug Alias NameTP-5809
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNon-receptor tyrosine-protein kinase TNK1 inhibitors
TargetsNon-receptor tyrosine-protein kinase TNK1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTolero Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesSumitomo Dainippon Pharma Oncology Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A